(Q51769473)

12 April 2018

title

Bleeding tendency and impaired platelet function in a patient carrying a heterozygous mutation in the thromboxane A2 receptor. (English)

1 reference

12 April 2018

1 reference

T Kamae

1

1 reference

12 April 2018

K Kiyomizu

2

1 reference

12 April 2018

T Nakazawa

3

1 reference

12 April 2018

S Tadokoro

4

1 reference

12 April 2018

H Kashiwagi

5

1 reference

12 April 2018

S Honda

6

1 reference

12 April 2018

Y Kanakura

7

1 reference

12 April 2018

Y Tomiyama

8

1 reference

12 April 2018

publication date

1 May 2011

1 reference

12 April 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

12 April 2018

volume

9

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

1040-1048

1 reference

12 April 2018

Platelet activation and atherothrombosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Cloning and expression of cDNA for a human thromboxane A2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

SHPS-1 negatively regulates integrin alphaIIbbeta3 function through CD47 without disturbing FAK phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

A potential role for α-actinin in inside-out αIIbβ3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

GPCR monomers and oligomers: it takes all kinds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04245.X

10.1111/J.1538-7836.2011.04245.X

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018